QBIO - Q BioMed insider Aedesius to invest up to $30M in the company

Q BioMed ([[QBIO]] +5.3%) signed a securities purchase agreement with privately-owned U.K.-based healthcare and technology aggregator Aedesius wherein latter has the opportunity to buy ~43% of the outstanding QBIO shares for $30M. The transaction is structured as an initial investment of $5M with an additional $15M by Sep.30, 2021 with 50% warrant coverage allowing an additional $10M investment within 120 days.The unit price is set at $1.25/share, a 31% premium to May 10 closing price.Post-money company valuation after initial closings will be ~$58M using purchase price of $1.25.

For further details see:

Q BioMed insider Aedesius to invest up to $30M in the company